FLT-PET
Showing 1 - 25 of 4,660
Advanced Cancers Trial in Houston (PET Scan, FLT)
Active, not recruiting
- Advanced Cancers
- PET Scan
- FLT
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)
Recruiting
- Brain Tumor
- Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 6, 2022
Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)
Completed
- Pancreatic Adenocarcinoma
- 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 10, 2022
FLT-PET / MRI Brain Mets
Recruiting
- Brain Metastases
- Radionecrosis
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 6, 2022
Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)
Active, not recruiting
- Breast Neoplasm
- +2 more
- [18F]FLT
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Aug 16, 2022
Image, Body, Cervix Cancer Trial in Singapore ([18F]FLT-PET/MRI body scan)
Recruiting
- Image, Body
- Cervix Cancer
- [18F]FLT-PET/MRI body scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Apr 27, 2022
Small Cell Lung Cancer Trial in Copenhagen (FLT-PET, MRI)
Completed
- Small Cell Lung Cancer
- FLT-PET
- MRI
-
Copenhagen, DenmarkDept. of Clinical Physiology, Nuclear Medicine and PET, Rigshosp
May 3, 2022
Advanced Cancer Trial in Houston (FLT-PET)
Completed
- Advanced Cancer
- FLT-PET
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))
Active, not recruiting
- Graft Vs Host Disease
- Fluorothymidine (FLT)
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Mar 21, 2022
Response to Immune Checkpoint Blockade in Metastatic Melanoma
Completed
- Melanoma
- F-FDG PET/CT
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jul 7, 2022
Non Small Cell Lung Cancer (NSCLC) Trial in Toronto (FLT-PET)
Active, not recruiting
- Non Small Cell Lung Cancer (NSCLC)
- FLT-PET
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 1, 2021
Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)
Completed
- Neurofibromatosis
- MPNST
- MRI, FDG-PET/CT scans
- [18F]-FLT-PET/CT scans
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
NSCLC, Starting Pemetrexed Based Therapy, Unresectable Cancer Trial in Philadelphia (Baseline 18F-thymidine (FLT) PET/CT,
Terminated
- Non-small Cell Lung Cancer
- +2 more
- Baseline 18F-thymidine (FLT) PET/CT
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
May 11, 2021
Brain Tumors Trial in Boston ([18F] FLT)
Active, not recruiting
- Brain Neoplasms
- [18F] FLT
-
Boston, MassachusettsChildren's Hospital, Boston
Aug 15, 2021
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large
Completed
- Lymphoma
- +2 more
- FLT-PET/CT
- +2 more
-
Los Angeles, California
- +3 more
May 6, 2021
[18F] Flourothymidine PET/CT Imaging for Gynecologic Cancers
Completed
- Gynecologic Cancer
- [18F]Fluorothymidine (FLT) PET/CT Imaging
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 5, 2021
Cancer, Brain Tumors Trial in Salt Lake City (FLT-PET Imaging)
Completed
- Cancer
- Brain Tumors
- FLT-PET Imaging
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 20, 2021
Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)
Completed
- Cancer
- Non Small Cell Lung Cancer
- PET Imaging
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Dec 16, 2021
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)
Recruiting
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Dexamethasone
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Tumors of the CNS Trial in Boston (18F-FLT, PET Imaging)
Terminated
- Tumors of the Central Nervous System
- 18F-FLT
- PET Imaging
-
Boston, MassachusettsChildren's Hospital Boston
Oct 12, 2021
Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha
Unknown status
- Essential Thrombocythemia
- +2 more
- Diagnostic (18F-FLT PET/CT)
-
Doha, QatarNational Center for Cancer Care & Research (NCCCR)
Sep 27, 2020
FLT-PET/MRI for Early Response Monitoring to Novel Cancer
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- fluorine F 18 fluorothymidine
- +2 more
-
Cleveland, OhioCase Comprehensive Cancer Center
Sep 17, 2020
Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha
Terminated
- Essential Thrombocythemia
- +3 more
- Diagnostic (18F-FLT PET/CT)
-
Doha, QatarNational Center for Cancer Care & Research (NCCCR)
Aug 10, 2020